Longterm Followup After Tapering Mycophenolate Mofetil During Maintenance Treatment for Proliferative Lupus Nephritis

被引：16

作者：

Laskari, Katerina ^{[1
]}

Tzioufas, Athanasios G. ^{[1
]}

Antoniou, Anna ^{[2
]}

Moutsopoulos, Haralampos M. ^{[1
]}

机构：

[1] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece

[2] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece

来源：

JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 07期

关键词：

LUPUS NEPHRITIS; MAINTENANCE TREATMENT; MYCOPHENOLATE MOFETIL; CLASSIFICATION; ERYTHEMATOSUS; THERAPY;

D O I：

10.3899/jrheum.101249

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective. To determine the timing for safe reduction of mycophenolate mofetil (MMF) dose during remission-maintenance therapy of proliferative lupus nephritis. Methods. The study population consisted of 44 patients evaluated retrospectively; MMF dose was empirically tapered in 18/44 patients until the latest observation. Results. Patients reducing MMF <= 18 months after remission/complete remission had a 6.8-fold/6.3-fold higher risk of relapse compared to those taking a stable dose (p = 0.001, p = 0.011, respectively). Reducing MMF later than 18 months was not associated with increased relapse rates. Conclusion. Reducing MMF > 1.5 years after remission/complete remission seems to warrant drug tapering without increased risk of disease flare in proliferative lupus nephritis. (J Rheumatol First Release April 15 2011; doi:10.3899/jrheum.101249)

引用

页码：1304 / 1308

页数：5

共 50 条

[1] Longterm Followup After Tapering Mycophenolate Mofetil During Maintenance Treatment for Proliferative Lupus Nephritis
Jourde-Chiche, Noemie
Daugas, Eric
JOURNAL OF RHEUMATOLOGY, 2011, 38 (11) : 2490 - 2490
[2] Effect of maintenance treatment with mycophenolate mofetil on chronic inflammatory status in proliferative lupus nephritis
Balletta, Mario
Esposito, Pasquale
Del Prete, Marco
De Cicco, Marco
Marotta, Paola
Andrietti, Marco
Procino, Alfredo
Bisesti, Vincenzo
Postiglione, Loredana
Cianciaruso, Bruno
Russo, Domenico
Memoli, Bruno
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 93 - 94
[3] Mycophenolate mofetil for the induction and maintenance treatment of lupus nephritis
Gonzalez-Rivera, Tania C.
McCune, Joseph
IMMUNOTHERAPY, 2011, 3 (12) : 1431 - 1440
[4] Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis
Lenz, O
Fornoni, A
Contreras, G
DRUGS, 2005, 65 (17) : 2429 - 2436
[5] Defining the Role of Mycophenolate Mofetil in the Treatment of Proliferative Lupus Nephritis
Oliver Dr Lenz
Alessia Fornoni
Gabriel Contreras
Drugs, 2005, 65 : 2429 - 2436
[6] Mycophenolate Mofetil versus Azathioprine for Maintenance Treatment of Lupus Nephritis
Kaballo, Babikir G.
Ahmed, Ahmed Elias
Nur, Musa Mohammed
Khalid, Ismail Osman
Abu-Aisha, Hasan
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (04) : 717 - 725
[7] Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide
Contreras, G
Tozman, E
Nahar, N
Metz, D
LUPUS, 2005, 14 : S33 - S38
[8] The 10-Year Followup of Nephritis Trial Comparing Azathioprine and Mycophenolate Mofetil for Longterm Immunosuppression of Lupus Nephritis.
Tamirou, Farah
D'Cruz, David
Sangle, Shirish
Remy, Philippe
Vasconcelos, Carlos
Fiehn, Christoph
Ayala Gutierrez, Maria del Mar
Gilboe, Inge-Margrethe
Tektonidou, Maria
Blockmans, Daniel
Ravelingien, Isabelle
le Guern, Veronique
Depresseux, Genevieve
Guillevin, Loic
Cervera, Ricard
Houssiau, Frederic A.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S426 - S427
[9] The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease
Dalton, Kristen
Smith, Maxwell
Thurman, Joshua M.
CLINICAL KIDNEY JOURNAL, 2010, 3 (04): : 346 - 348
[10] Progression of lupus nephritis during treatment with mycophenolate mofetil
Ahmadi-Simab, K
Lamprecht, P
Gross, WL
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) : 1179 - 1180

← 1 2 3 4 5 →